Arcutis Biotherapeutics, Inc. ARQT Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed October 28, 2025, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s net margin?
- Arcutis Biotherapeutics, Inc. (ARQT) reported net margin of -13.9% in Q3 2025.
- How has Arcutis Biotherapeutics, Inc.'s net margin changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s net margin increased by 90.1% year-over-year, from -141% to -13.9%.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s net margin?
- Over 2 years (2022 to 2024), Arcutis Biotherapeutics, Inc.'s net margin has grown at a -90.8% compound annual growth rate (CAGR), from -8,449.8% to -71.3%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.